From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
November 10, 2020
Philadelphia, PA, November 10, 2020 – IntegriChain, delivering Life Sciences’ only comprehensive data and business process platform for market access, today announced that the Company now has 25 customers of all size and complexity for its Gross-to-Net (GTN) offerings. IntegriChain’s GTN solutions enable Life Sciences Market Access and Finance teams to improve forecast accuracy, GTN modeling, and financial close efficiency. The GTN suite comprises GTN Accrual Management and GTN Accrual Forecasting, and newly announced GTN Analytics (press release). IntegriChain’s GTN offerings are delivered in flexible options as Managed Services (which were launched just a year ago), software-as-a-service (SaaS), or hybrid implementations.
“We are thrilled with the market uptake of our GTN solutions,” said Jennifer Sharpe, Executive Director, Gross-to-Net. “The more than two dozen manufacturers – representing all segments of the Life Sciences industry from emerging innovators to mid-tier and Big Pharma enterprises – share our vision for a single, credible system of truth and forecast accuracy to drive decision-making and strategy. We are excited to partner with these innovative manufacturers as we continue to grow and expand our GTN offerings.”
IntegriChain Sponsors CBI GTN 2020
As leaders in GTN, IntegriChain is a platinum sponsor of CBI GTN 2020, which begins virtually on November 16. Throughout the conference, IntegriChain experts will share their GTN thought leadership:
About IntegriChain’s GTN Solutions IntegriChain offers a full suite of GTN Solutions, including:
GTN Accrual Management. An end-to-end solution for Market Access and Finance departments, pre-configured for all standard line items with robust out-of-the-box accrual methodologies, including inventory and pipeline adjustments to accruals, balance sheet reconciliation to ERP systems, and true-up functionality.
GTN Accrual Forecasting. Based on industry-standard forecast methodologies configured for each liability line item with the ability to execute multiple scenario analyses for forecasts along with functionality to compare scenarios to improve forecast accuracy, GTN modeling, and financial close efficiency.
GTN Analytics. Delivering visibility to comprehensive market access datasets that power the accuracy of GTN accruals and forecasting processes, best practices GTN reports and metrics, and visualizations of GTN trends that allow for better accrual and net-price predictability and decision-making.
GTN Advisory. IntegriChain industry experts routinely advise manufacturers on GTN readiness for launch, GTN process assessments, and GTN market analysis.
About IntegriChain IntegriChain delivers Life Sciences’ only comprehensive data and business process platform for market access. More than 250 manufacturers rely on IntegriChain’s ICyte Platform of analytics, applications, managed services, and expert advisors to power their market access operations and harness the value of their channel, patient and payer data. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA, with offices in Ambler, PA; Somerset, NJ, Raleigh, NC, and Pune, India. For more information, visit www.integrichain.com, or follow us on Twitter @IntegriChain and LinkedIn.
Contact Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | Jennifer@sagestrat.com
Register Now
Webinars & Resources
See List